CGTX Cognition Therapeutics, Inc.
Healthcare$1.24-1.59%ClosedMarket Cap: $91.2M
As of 2026-05-26
Insider Statistics (Q1 2026)
Acquisitions
3
Dispositions
5
Buy/Sell Ratio
0.60
Net Shares
+1,256,932
Shares Acquired
1,400,000
Shares Disposed
143,068
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon May 04 | Doyle John Brendan | officer: Chief Financial Officer | Sell | 8,567 | $1.28 | 618,942 |
| Mon Apr 20 | Ricciardi Lisa | director, officer: CEO & President | Buy | 9,175 | $1.10 | 1,715,851 |
| Mon Apr 20 | Doyle John Brendan | officer: Chief Financial Officer | Buy | 10,000 | $1.13 | 627,509 |
| Mon Apr 20 | Caggiano Anthony | officer: Chief Medical Officer | Buy | 10,000 | $1.11 | 874,906 |
| Wed Feb 18 | Ricciardi Lisa | director, officer: CEO & President | Sell | 5,850 | $1.12 | 1,706,676 |
| Wed Feb 18 | Doyle John Brendan | officer: Chief Financial Officer | Sell | 1,560 | $1.12 | 617,509 |
| Wed Feb 18 | Caggiano Anthony | officer: Chief Medical Officer | Sell | 4,680 | $1.12 | 864,906 |
| Thu Feb 05 | Ricciardi Lisa | director, officer: CEO & President | Sell | 51,704 | $1.03 | 1,712,526 |
| Thu Feb 05 | Ricciardi Lisa | director, officer: CEO & President | Sell | 26,036 | $1.12 | 1,764,230 |
| Thu Feb 05 | Ricciardi Lisa | director, officer: CEO & President | Sell | 800,000 | $0.00 | 1,790,266 |
| Thu Feb 05 | Doyle John Brendan | officer: Chief Financial Officer | Sell | 26,921 | $1.03 | 619,069 |
| Thu Feb 05 | Doyle John Brendan | officer: Chief Financial Officer | Sell | 200,000 | $0.00 | 645,990 |
| Thu Feb 05 | Caggiano Anthony | officer: Chief Medical Officer | Sell | 11,488 | $1.12 | 896,505 |
| Thu Feb 05 | Caggiano Anthony | officer: Chief Medical Officer | Sell | 400,000 | $0.00 | 907,993 |